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Abstract
Objective—Hospital environmental surfaces are frequently contaminated by microorganisms. 
However, the causal mechanism of bacterial contamination of the environment as a source of 
transmission is still debated. This prospective study was performed to characterize the nature of 
multidrug-resistant organism (MDRO) transmission between the environment and patients using 
standard microbiological and molecular techniques.
Setting—Prospective cohort study at 2 academic medical centers.
Design—A prospective multicenter study to characterize the nature of bacterial transfer events 
between patients and environmental surfaces in rooms that previously housed patients with 1 of 4 
‘marker’ MDROs: methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, 
Clostridium difficile, and MDR Acinetobacter baumannii. Environmental and patient 
microbiological samples were obtained on admission into a freshly disinfected inpatient room. 
Repeat samples from room surfaces and patients were taken on days 3 and 7 and each week the 
patient stayed in the same room. The bacterial identity, antibiotic susceptibility, and molecular 
sequences were compared between organisms found in the environment samples and patient 
sources.
Results—We enrolled 80 patient–room admissions; 9 of these patients (11.3%) were 
asymptomatically colonized with MDROs at study entry. Hospital room surfaces were 
contaminated with MDROs despite terminal disinfection in 44 cases (55%). Microbiological 
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Bacterial Transfer events either to the patient, the environment, or both occurred in 12 patient 
encounters (18.5%) from the microbiologically evaluable cohort.
Conclusions—Microbiological Bacterial Transfer events between patients and the environment 
were observed in 18.5% of patient encounters and occurred early in the admission. This study 
suggests that research on prevention methods beyond the standard practice of room disinfection at 
the end of a patient’s stay is needed to better prevent acquisition of MDROs through the 
environment.
Hospital environmental surfaces are frequently contaminated by microorganisms.1 When 
contaminated, such surfaces can potentially act as vectors for transmission of bacteria that 
can lead to healthcare-associated infections (HAIs).2 Although contaminated surfaces have 
been hypothesized to play an important role in the causal pathway of HAIs, the nature, 
direction, persistence, and quantity of bacterial transfer between surfaces and patients 
remain poorly understood.
Nevertheless, the concept of bacterial contamination of the environment as a source of 
transmission is still debated. Flaws with previous studies have included (1) studies taking 
place during an outbreak setting, (2) suboptimal study design,3 and (3) lack of molecular 
epidemiology to show correlation between isolates from the environmental and those from 
patients. However, our group recently reported results from a large, multicenter randomized 
controlled trial on interventions to improve disinfection practices.4 Although our study only 
focused on strategies that improve terminal room disinfection, the results suggest that the 
environment is responsible for at least 10%–30% of MDRO acquisitions.
Thus, we undertook this prospective multicenter study as a substudy of our large trial to 
characterize the nature of MDRO transmission between the environment and patients using a 
combination of standard microbiological and molecular techniques. The objective of this 
study was to determine whether, when, and in what direction epidemiologically important 
pathogens transfer between patients and surfaces within hospital rooms.
Methods
We performed a prospective cohort study at 2 hospitals: Duke University Hospital (a 921-
bed tertiary-care academic medical center in Durham, North Carolina) and Duke Regional 
Hospital (a 250-bed community hospital in Durham, North Carolina). The study was 
designed to characterize the baseline and temporal profile of microorganisms on 
environmental surfaces of acute-care hospital rooms and on patients admitted to these newly 
disinfected rooms. We sought to characterize the nature of bacterial transfer events between 
patients and environmental surfaces using 4 ‘marker’ MDROs: methicillin-resistant 
Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Clostridium 
difficile, and multidrug-resistant (MDR) Acinetobacter baumannii. These organisms were 
chosen due to their importance as pathogens in HAIs and their propensity to contaminate 
and persist on hospital surfaces.2
The study was approved by the Duke University Health System Institutional Review Board 
and was registered on ClinicalTrials.gov (trial no. ). Additionally, the current study was 
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performed in the study hospitals contemporaneously with the BETR Disinfection study (trial 
no. ),4 the first controlled, cluster-randomized multicenter study investigating the efficacy of 
reducing incidence of HAIs with use of enhanced terminal cleaning strategies. In short, 
participating hospitals were randomized to terminally clean all patient rooms with (1) 
reference (quaternary ammonium disinfectant except for C. difficile, for which bleach was 
used); (2) UV (quaternary ammonium disinfectant and disinfecting ultraviolet [UV-C] light 
except for C. difficile, for which bleach and UV-C were used); (3) bleach only; or (4) bleach 
and UV-C. Every strategy was used at each hospital in 4 randomly assigned consecutive 7-
month periods. Thus, each participating hospital would implement all 4 cleaning strategies 
for 6 months with 1 month of washout between different cleaning methods. The routine 
daily cleaning of the patient rooms continued during the study with quaternary ammonium 
for all rooms or bleach for rooms that had housed patients with Clostridium difficile 
infection (CDI) according to standard practice at participating hospitals. We enrolled 20 
subjects for each type of terminal disinfection strategy.
Subject enrollment
We prospectively identified subjects for enrollment using the admissions and transfer data 
from of the health system electronic medical record. All patients admitted to newly cleaned 
rooms at participating hospitals were eligible. To enhance the ability to detect and document 
bacterial transmission events between patients and hospital environments, study personnel 
specifically sought out (1) patients housed in rooms whose antecedent patient was placed on 
contact precautions for any reason and (2) patients with anticipated hospital stay of≥48 
hours. Informed consent was obtained from all subjects enrolled in the study. Patients were 
excluded if they had already been placed in the newly cleaned room prior to screening 
procedures, baseline sampling, or informed consent.
Specimen collection
Study personnel made study visits to collect specimens from the patient and environmental 
room surfaces at the time of enrollment (day 0) and at defined intervals thereafter (ie, study 
days 3 and 7 and each week after study enrollment). Importantly, the environmental 
specimens were obtained on day 0 after terminal disinfection but prior to subject entry into 
the room. Where possible, a final set of specimens was collected from the patient and 
environmental room surfaces on the day of discharge from the room. Study personnel 
performed hand hygiene and donned contact isolation equipment prior to entering the room 
and taking microbiological specimens to reduce introduction of microorganisms.
Study personnel obtained 2 microbiological swabs from 4 body sites (nares, oropharynx, 
axilla, and perineum) at each study visit5, 6 and a fecal specimen if available on the day of 
the visit.7, 8 Microbiological samples were also collected from 7 high-frequency touch 
surfaces in the hospital room of the enrolled subject; these surfaces included the bed rail, 
overbed table, top of the nearest bedside table, arm rest of chair, sink, toilet seat, and the 
floor of the shower bloc.9 Each surface area was sampled repeatedly using 10 individual 
Rodac plates (5 for aerobic and 5 for anaerobic culture) to enhance microbiological yield 
and to reduce sampling error.10
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Outcomes
We identified 2 primary outcomes of interest: (1) The baseline and subsequent patterns of 
patient colonization and hospital surface contamination, and (2) the number of 
microbiological and molecularly proven bacterial transfer events between hospital surfaces 
and patients. We also identified 2 secondary outcomes of interest: (1) the direction and 
timing of bacterial transfer events and (2) the clonal relatedness of bacterial isolates involved 
in transfer events. We defined microbiological bacterial transfer (MBT) events as the 
detection of microorganisms from patients and environmental surfaces of the same genus, 
species, and antibiotic susceptibility (for MRSA and VRE). The likely direction of bacterial 
transmission was surmised based on the sequence of detection. For example, if an organism 
was found on environmental surfaces prior to identification in patient specimens, we 
categorized the MBT event as an environment-to-patient transmission. If an organism was 
detected on patient and environmental specimens at the same study visit, the direction of the 
MBT was defined as indeterminate.
Microbiological methods for patient-derived specimens, specimens from environmental 
sampling and the molecular analysis and relatedness testing are described in detail in the 
supplemental appendix.
Statistical analysis
We used standard descriptive statistics, including medians and interquartile ranges (IQRs) 
for nonnormally distributed continuous variables. For quantitative analyses of data from 
Rodac plates, culture results were aggregated to obtain the number of colony-forming units 
(CFUs) per environmental site, not per plate.10
Results
Demographics
We enrolled and collected data on 80 patient–room encounters that occurred in 68 general 
ward rooms; 67 of the patients (84%) were white, and 54 (68%) were female (Table 1). 
Collectively, 79% of the enrolled patients were admitted under 2 medical services: general 
medicine and oncology/hematology. The median length of hospital stay for enrolled patients 
was 4.9 days. Of the 80 patients, 15 (18.8%) were discharged before the day 3 study visit 
and provided only baseline specimens (Fig. 1). The remaining 65 patient–room encounters 
(81.3%) provided the baseline and at least 1 other pair of patient–environmental specimens 
on subsequent study visits for comparison; this group of 65 patients were considered the 
microbiologically evaluable (ME) cohort.
Baseline and temporal pattern of patient colonization and surface contamination
In total, 9 patients (11.3%) were asymptomatically colonized with MDROs at study entry: 
MRSA colonization was observed in 6 encounters (7.5%), VRE colonization was observed 
in 2 encounters (2.5%), and C. difficile colonization was found in 2 encounters (2.5%). 
Notably, 1 of these patients (1.25%) was concurrently colonized with MRSA and C. 
difficile.
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Hospital room surfaces were contaminated with MDROs despite terminal disinfection in 44 
of 80 patient rooms (55%) at time of study enrollment. Clostridium difficile was detected in 
21 rooms (26.3%); VRE was detected in 18 rooms (22.5%); MRSA was detected in 15 
rooms (18.8%); and MDR Acinetobacter was detected in 9 rooms (11.3%). Contamination 
with multiple MDROs was observed in 19 (23.8%) rooms; 2 MDROs were identified in 17 
rooms (21.3%), and 3 MDROs (2.5%) were identified in 2 rooms.
The bioburden of MDROs on tested hospital surfaces was generally low at enrollment 
(median, 6 CFU of MDROs/cm2; interquartile range [IQR], 2–16 CFU/cm2). Notably, the 
bioburden was similarly low regardless of the organism detected (Table 2).
Bacterial transfer events
We detected 12 microbiological bacterial transfer (MBT) events (18.5%) among the 65 
patients of the ME cohort: 2 (16%) were associated with MRSA, 5 (42%) were associated 
with VRE, and 5 (42%) were related to C. difficile (Tables 3). We categorized these 12 MBT 
events into 3 categories based on likely direction of bacterial transfer (Table 3): 4 MBT 
events (33%) occurred from patient to environment; 4 events (33%) occurred from 
environment to patient; and in 2 environment-to-patient transfer events (50%), a molecularly 
similar organism was detectable on hospital room surfaces at baseline. The other 2 apparent 
environment-to-patient MBT events involved molecularly dissimilar organisms of the same 
genus and species. Notably, 4 MBT events (33%) were of indeterminate direction because a 
marker organism was detectable in both the patient and the environment at the same post-
baseline visit.
We attempted to perform molecular relatedness testing on patient and environmental isolates 
obtained from these 12 MBT events; however, 3 patient-derived VRE isolates failed to 
amplify despite repeated attempts. Thus, complete clonal relatedness data were only 
available for 9 (75%) of 12 MBT events (Table 3). Molecular sequencing of isolates 
captured in MBT events showed that MDRO transmission frequently involved both 
molecularly related and molecularly dissimilar isolates of the same organism. For instance, 3 
MBT events (33%) involved molecularly dissimilar isolates (ie, not true transmission 
events), and 4 other MBT events (44%) involved a combination of molecularly dissimilar 
and molecularly related isolates. Only 2 MBT events (22%) involved strictly molecularly 
related isolates.
Moreover, 4 distinct MRSA pulsotypes were identified in the 2 MBT events (Supplemental 
Fig. 1). None of the pulsotypes matched control MRSA types tested (ie, USA 100, 200, 300, 
400, 500, 600, 700, 800, 1000, or 1100). In 1 patient-to-environmental MBT event, the 
environmental isolates were identical to the patient-derived isolates and all isolates belonged 
to pulsotype group III. In a second patient-environmental set in which the direction of MBT 
was classified as indeterminate, the patient isolates belonged to MRSA pulsogroup I and 
matched 8 environmental isolates. Interestingly, 4 other types of MRSA were also 
encountered in the environment, including 2 other distinct pulsotype groups (MRSA groups 
II and IV) and 2 MRSA singleton isolates (ie, without a molecular match).
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Five MBT events were VRE related (Tables 3); 1 event was from patient to environment, 1 
event from environment to patient, and 3 other events were indeterminate. While 7 patient 
isolates were available, they produced only 2 interpretable PFGE patterns, and 91 
environmental isolates produced 58 PFGE patterns. Among all isolates analyzed, 4 were 
major PFGE pulsotypes of VRE with at least 2 isolates of>80% similarity, but 14 singleton 
isolates were identified (Supplemental Fig. 2). Furthermore, the VRE pulsotypes were not 
shared between different patient–environment sets.
For C. difficile, we identified 5 C. difficile-related MBT events; they produced interpretable 
ribotype patterns from 8 patient isolates and 23 environmental isolates. Three MBT events 
involved molecularly related isolates: 2 events were due to environmental to patient transfer 
and 1 event was due to patient to environment transfer. Also, 2 MBT events involved 
molecularly dissimilar isolates of C. difficile (ie, not true transmissions). Environmental 
isolates of C. difficile also showed the most variability in ribotype patterns (Supplemental 
Fig. 3). All patient–environment sets included environmental isolates that had ribotype 
patterns different from the patient isolates.
Of the 12 MBT events, time-to-event analyses showed that 80% of the documented 
transmission, regardless of direction, occurred within 3 days of identifying a target MDRO 
from any patient or environmental site (Fig. 2).
Specific examples of bacterial transmission events
Several of the observed MBTs were complex and deserve specific narrative beyond 
aggregated statistical information.
Patient to environment
Patient A was colonized with MRSA in the oropharynx and the perineum at study 
enrollment. At the same initial study visit, none of the environmental surfaces in the 
patient’s room were contaminated with an MDRO. On study day 3, the oropharyngeal 
carriage of MRSA was again detected. In addition, a MRSA with identical PFGE pulsotype 
was also detected from environmental samples obtained from bed rails. This patient did not 
have a documented HAI with MRSA.
Patient B had no MDRO colonization at enrollment. Enrollment samples from recently 
terminally cleaned environment revealed C. difficile on bathroom floor surfaces. On day 3, 
the same C. difficile was still detected on the bathroom floor. Surprisingly, the patient was 
asymptomatically colonized with a second and different strain of C. difficile at the same 
study visit on day 3 (strain B). Patient B developed symptoms of CDI on day 7, and the 
second strain of C. difficile was detected in stool specimens. Subsequently, we found 
evidence of environmental contamination with the second strain of C. difficile on chair arm 
and in the patient room sink 7 and 14 days following the onset of CDI, respectively. Without 
sequential patient and environmental sampling and the molecular confirmation, the 
environment would have been blamed as the source for C. difficile acquisition and infection.
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Environment to patient
Neither Patient C nor the environmental surfaces were colonized with any of the marker 
MDROs at enrollment. On day 3, C. difficile isolates were detected on the sink and the bed 
rail. On day 14, the patient’s perineal specimen showed the same clonal type of CDI as that 
recovered on day 3 from the environmental specimen. The patient remained asymptomatic 
for CDI throughout the duration of the study and the hospital stay.
Discussion
We used a prospective study design and molecular techniques to study the transmission of 
MDROs between patients and surfaces of hospital rooms. The most important finding from 
the current study is the demonstration of microbiological bacterial transfer events in 12 
patient encounters (18.5%) from the ME cohort (Fig. 1). Molecular testing of specimens 
showed that 6 encounters (66.7% of the 9 ME cohort with molecular data and 9.2% of the 65 
evaluable patients) involved molecularly identical strains of MDRO. Indeed, 7.5% of all 
hospital-room encounters showed transfer of clonally identical MDROs. Perhaps most 
importantly, we identified 2 encounters (3%) in which the patient acquired an MDRO 
present in the environment at the time of admission; both events were confirmed 
environment-to-patient transmissions involving C. difficile.
We believe that these observed rates of MDRO transmission are underestimates of the true 
bacterial transfer phenomenon for 2 primary reasons: (1) limitations in sampling and (2) lack 
of sensitivity of current microbiological methods. Furthermore, we only tracked bacterial 
transmission using 4 ‘marker’ MDROs; we hypothesize that bacterial transmission occurs at 
a larger scale in real-life healthcare settings, involving wild-type species and organisms of 
varying drug-resistances, such as those that have extended-spectrum β-lactamase (ESBL), 
TEM and SHV, or AmpC resistance determinants.
Our baseline microbiological samples from enrolled patients provided a representative 
glimpse into the prevalence of MDRO colonization in our subjects. Indeed, 11.3% of the 
enrolled patients were asymptomatically colonized with at least 1 type of MDRO, a finding 
consistent with other studies.11 This prevalence underscores the importance of 
understanding the local antimicrobial susceptibility patterns of organisms to guide 
appropriate and effective antibiotic choice.
The baseline microbiological cultures from environmental sources showed that 55% of 
hospital patient rooms still had at least 1 surface with detectable microbial growth of 
MDROs at time of patient admission despite terminal disinfection procedures. The average 
level of surface contamination was low but was clearly sufficient for documented 
transmission to patients. These environmental microbiological data from our study add 
weight to recent investigations showing that the carrier status of a room’s prior occupant can 
increase risk of MDRO acquisition for the subsequent occupant.12, 13 These results support 
the urgency of investigating and implementing enhanced terminal-cleaning procedures to 
further reduce residual microbial contamination during patient room turnover and to 
minimize the risk of bacterial transmission.4 Finally, these findings occurred despite 
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concurrent application of enhanced terminal room disinfection strategies and high rates of 
compliance of surface cleaning.4
Our observation of low-level bacterial contamination after terminal cleaning highlights 
another important limitation in current literature; there is no consensus method for assessing 
or defining a surface as “clean.”14 The establishment of a definition or target of “clean” 
surface is difficult, but it is needed for future technologies and real-world interventions to 
reduce risk for pathogen transmission.14
Throughout the hospital stay, we observed that hospital room surfaces became contaminated 
with MDROs. We hypothesized that these new environmental isolates were introduced 
during the hospitalization through one or a combination of the following sources: 
importation through healthcare staff, contaminated fomites brought into the room (eg, trays, 
medical equipment, etc.), visitors, or unmasking of prior bacterial colonization of the patient 
through triggers such as antibiotic selection pressure. Where bacterial-transmission events 
were noted, most occurred early (within 3 days) into the admission of a newly cleaned room. 
Furthermore, bacterial transmission from the environment resulted in both asymptomatic 
carriage and symptomatic infection among the patients. The early transmission of MDRO 
between the environment and patient is an important observation and points to the 
opportunity for development of effective prevention strategies of bacterial transmission.15, 16
Our study was limited by the modest number of patients and rooms we could feasibly enroll 
and study using microbiological and molecular techniques. The representativeness of our 
study of usual clinical practice was also potentially lowered because the study targeted 
rooms that previously housed patients on contact precautions. Second, our microbiological 
sampling was not always timed to occur before daily cleaning by environmental services 
staff; thus, some surfaces may have been freshly cleaned prior to sampling. Furthermore, we 
recognize that external vectors could introduce organisms to the hospital room environment 
and the patient throughout the study period (eg, healthcare staff or visitors). However, other 
factors also counterbalance these external forces and reduce detection of transferred 
organisms, such as treatment with concurrent antibiotic and/or a high hand hygiene 
performance rate that is greater than published literature (>90% compliance).17 We believe 
that these limitations suggest that our findings represent the minimum impact of the 
environment on acquisition of MDROs. Furthermore, this endeavor represents the largest 
prospective study to confirm and quantify clonal bacterial transmission between hospitalized 
patients and environmental surfaces using molecular techniques. Our microbiological 
methods were important for distinguishing between potential and definitive transmission 
events.
These findings have several important implications for future studies and interventions. The 
observed transmission of selected MDROs are markers of larger-scale bacterial admixing 
between the microbial flora of the hospital environment and that of the patient. If microbial 
transmission occurs early, readily, and frequently between patients and the environment, as 
shown in the study, the standard hospital cleaning practice of performing a detailed room 
disinfection only at the end of patient stay (ie, “terminal” cleaning) may be inadequate to 
prevent the acquisition of MDROs through the environment. Indeed, these results should 
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compel us to develop new technologies and interventions to achieve safe continuous 
environmental disinfection within the healthcare setting. Future effort and research to reduce 
transmission of MDROs through the healthcare environment must improve upon the status 
quo approach to environmental disinfection.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Included and excluded study patients and results of bacterial transfer events. Percentages of 
the total population displayed. MTE, microbiological transfer event; ME, microbiologically 
evaluable.
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Fig. 2. 
Time-to-event analysis showing time from first positive bacterial culture from any source to 
documented transfer of clonally identical bacteria between patients and room surfaces.
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Table 1
Demographic and Admission Characteristics of Subjects Enrolled in the Current Study
Variable Full Cohort (n=80), No. (%)
Age, y, median (IQR) 60 (55–69)
Female 54 (68)
Caucasian 67 (84)
General medicine service 22 (28)
Oncology 29 (36)
Only 1 collection 15 (19)
2 collections 48 (60)
≥ 3 collections 17(21)
Length of hospital stay, d median (IQR) 4.9 (3.1–12.0)
Note. IQR, interquartile range.
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Table 2
Baseline Contamination of Hospital Surfaces at Enrollment by Pathogen
Variable MRSA VRE Clostridium difficile Acinetobacter
Rooms with contamination, no. (%) 15 (18.8) 18 (22.5) 21 (26.3) 9(11.3)
Median CFU/cm2 (IQR) 6(3–13) 8 (5–38) 3 (1–11) 4 (1–9)
Note. MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococci; CFU, colony-forming units; IQR, interquartile 
range.
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Table 3
Description of 12 Cases of Potential Microbiological Bacterial Transfer Eventsa
Patient Target MDRO
Terminal Clean 
Protocol
Patient- 
Environment
Environment-
Patient Indeterminate
Presence of 
Molecularly 
Related Isolates
Presence of 
Molecularly 
Discordant 
MDRO 
Isolatesb
A MRSA Bleach X X
B MRSA Bleach X X X
C VRE Quat. X X
D VREc Bleach + UV X
E VREc Bleach + UV X
F VREc Bleach + UV X
G VRE Bleach X X
H CDI Bleach X X X
I CDI Bleach X X
J CDI Quat. X X X
K CDI Quat. X X X
L CDI Quat. + UV X X
Total 12 4 (33%) 4 (33%) 4 (33%) 6 (50%) 7(58%)
Note. MRSA, methicillin resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococci; MDR ABC, multidrug-resistant Acinetobacter 
baumanii complex; Quat., quaternary ammonium; CDI, Clostridium difficile infection.
a
Terminal cleaning protocol used for disinfecting the room prior to admission: bleach, bleach+UV irradiation, Quat., Quat.+UV irradiation.
bSubjects could have both molecularly related and molecularly discordant transfer events if>1 ribotype of a target MDRO species was identified.
c
Molecular relatedness unknown due to noninterpretable pulsed-field gel electrophoresis (PFGE).
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